Progress on potentially less harmful alternatives to smoking
Over one million adult smokers have converted to IQOS, PMI’s leading
heated tobacco product
LAUSANNE, Switzerland--(BUSINESS WIRE)--Jan. 25, 2017--
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today
re-affirms its commitment to designing a smoke-free future. With more
than one million adult smokers who have converted to IQOS, momentum
continues to grow behind the company’s full-scale effort to market
smoke-free products that can ultimately replace cigarettes. PMI’s new
website offers a look into its vision for the future, and how its new
products can have a significant impact on adult smokers and society.
“Adult smokers are looking for product choices that offer the
satisfying taste, ritual, and pleasure they get from cigarettes, but
with far lower amounts of the harmful compounds found in smoke,”
said Tony Snyder, PMI Vice President of Communications. “After more
than ten years of research and development, today we have both the
science and the technology to make these products a reality for the
world’s 1.1 billion smokers.”
IQOS is one of four smoke-free products from PMI to address adult
smoker demand and varying preferences. It is a heated tobacco product
that was launched in late 2014 and is expected to be available in key
cities in over 30 markets in 2017.
Since 2008, PMI has hired over 400 scientists and experts and invested
over USD 3 billion in research, product development and scientific
substantiation. Results of scientific research to assess the
reduced-risk potential of IQOS are very promising, and the
company openly shares its scientific methodologies and findings for
independent third-party review and verification. In December 2016, PMI
submitted a Modified Risk Tobacco Product Application (MRTPA) for IQOS
to the U.S. Food and Drug Administration’s (FDA) Center for Tobacco
Products.
Snyder continued, “We’re optimistic about the future as we work to
progressively transition PMI’s existing cigarette business to
potentially less harmful alternatives. There is tremendous opportunity
to positively impact public health with the availability of better
choices than continued smoking, and we can’t do it alone. Contributions
from public-health experts, the scientific community and regulators will
greatly accelerate switching from cigarettes to smoke-free products.”
To learn more about how PMI is designing a smoke-free future, please
visit the new company website at www.pmi.com.
Philip Morris International Inc.
Philip Morris International Inc. (PMI) is the world’s leading
international tobacco company, with six of the world's top 15
international brands and products sold in more than 180 markets. In
addition to the manufacture and sale of cigarettes, including Marlboro,
the number one global cigarette brand, and other tobacco products, PMI
is engaged in the development and commercialization of Reduced-Risk
Products (RRPs). RRPs is the term PMI uses to refer to products that
present, are likely to present, or have the potential to present less
risk of harm to smokers who switch to these products versus continued
smoking. Through multidisciplinary capabilities in product development,
state-of-the-art facilities, and industry-leading scientific
substantiation, PMI aims to provide an RRP portfolio that meets a broad
spectrum of adult smoker preferences and rigorous regulatory
requirements. For more information, see www.pmi.com
and www.pmiscience.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170125005433/en/
Source: Philip Morris International
Media enquiries
Philip Morris International media office
T:
+41 (0)58 242 4500
E :media@pmi.com